<DOC>
	<DOCNO>NCT02444442</DOCNO>
	<brief_summary>The purpose study assess efficacy catheter-based renal denervation reduce blood pressure patient resistant hypertension compare sham procedure . Patients randomize RDN sham control 2:1 ratio . All participant switch single pill triple combination treatment prior procedure . A total 105 patient recruit study , 70 patient RDN arm 35 patient sham control arm . The duration study 36 month .</brief_summary>
	<brief_title>Sham Controlled Clinical Trial Renal Denervation Patients With Resistant Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>systolic BP ≥140mmHg ambulatory day time average ≥130mmHg despite concurrent treatment ≥3 antihypertensive drug renal artery anatomy ineligible treatment eGFR &lt; 15mL/min/1.73m2 ( use MDRD calculation ) myocardial infarction , unstable angina cerebrovascular accident within 3 month screen visit life expectancy &lt; 12 month female participant childbearing potential must negative pregnancy test prior treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Renal denervation</keyword>
	<keyword>Blood pressure</keyword>
	<keyword>Cardiovascular risk</keyword>
	<keyword>Target organ damage</keyword>
	<keyword>Sympathetic activity</keyword>
	<keyword>Non-compliance</keyword>
</DOC>